Strontium fructose 1,6-diphosphate prevents bone loss in a rat model of postmenopausal osteoporosis via the OPG/RANKL/RANK pathway. [electronic resource]
Producer: 20120730Description: 479-89 p. digitalISSN:- 1745-7254
- Animals
- Bone Density -- drug effects
- Bone and Bones -- drug effects
- Female
- Fructosediphosphates -- pharmacology
- Humans
- Immunologic Factors -- pharmacology
- Insulin-Like Growth Factor I -- analysis
- Osteoporosis, Postmenopausal -- blood
- Osteoprotegerin -- blood
- Oxidative Stress -- drug effects
- RANK Ligand -- blood
- Rats
- Rats, Sprague-Dawley
- Receptor Activator of Nuclear Factor-kappa B -- blood
- Signal Transduction
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.